Nyxoah (NYXH) Net Cash Flow Growth (3y) (2024 - 2026)
Nyxoah (NYXH) Net Cash Flow Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -16.59% |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -55.30% |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 39.87% |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 126.35% |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 2.16% |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -159.90% |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 78.59% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 36.49% |
| 10 | Nyxoah | 53.92 Mn | 100.91 Mn | 4.26 Mn | -8.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.29% |
| Dec 31, 2025 | -16.04% |
| Sep 30, 2025 | 118.68% |
| Jun 30, 2025 | 30.36% |
| Mar 31, 2025 | -21.67% |
| Dec 31, 2024 | 32.13% |
| Sep 30, 2024 | -65.72% |
| Jun 30, 2024 | -42.46% |
| Mar 31, 2024 | 79.20% |